Menu
- Microbiology
- Sexual Health
- Pregnancy & Fertility
- Point of Care Tests
- Autoimmune
- Coagulation & Haematology
- Drugs of Abuse
- Clinical Chemistry
- Research Biochemistry
- Food Safety Tests
Invitech is delighted to announce it has signed a distribution agreement with Reagena Oy Limited, Finland.
As a leading supplier of reagents for Vector Borne Diseases, Invitech is delighted to promote Reagena's ReaScan instruments and reagents for the detection of Tick Borne Encephalitis and CXCL13 in Lyme Neuroborreliosis, along with diagnostics for Hantaviruses plus stains for microbiology, haematology, cytology and pathology.
Our Partner, LDN, has announced the CE marking of ELISA assays for SARS-CoV-2
As the world continues the battle against the COVID-19 infections and the number of people hospitalized with severe infections increases, we would like to advise you of the interim guidelines recently released by the International Society of Thrombosis and Haemostasis (ISTH) on how health care professionals may manage bleeding disorders associated with COVID-19. While the majority of hospitalized patients initially present with single organ failure/respiratory failure, some patients progress to more systemic disease and multiple organ failure. The development of bleeding disorders has been found to be a marker of significantly poor prognosis in these patients.
Invitech's longstanding and trusted partner, LDN, has launched ELISAs for the qualitative detection of:
The manufacturer of the C6 ELISA kit has informed us that the product has been discontinued with immediate effect.
AlphaTec will be making some incremental changes to the NAC-PAC N30 product to provide more flexibility for lab end-users.